178 related articles for article (PubMed ID: 6358156)
1. Treatment of bladder carcinoma with irradiation combined with misonidazole.
Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
[TBL] [Abstract][Full Text] [Related]
2. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
Abratt RP; Barnes DR; Hammond JA; Sarembok LA; Tucker RD; Williams AM
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
Panis X; Nguyen TD; Froissart D; Demange L
Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
[TBL] [Abstract][Full Text] [Related]
4. Misonidazole combined with hyperfractionation in the management of malignant glioma.
Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
[TBL] [Abstract][Full Text] [Related]
5. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
Sealy R; Cridland S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
[TBL] [Abstract][Full Text] [Related]
6. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
Simpson JR; Bauer M; Wasserman TH; Perez CA; Emami B; Wiegensberg I; Zinninger M; Durbin LM
Int J Radiat Oncol Biol Phys; 1987 Jun; 13(6):861-7. PubMed ID: 3034841
[TBL] [Abstract][Full Text] [Related]
7. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
[TBL] [Abstract][Full Text] [Related]
8. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
Stadler B; Kärcher KH; Kogelnik HD; Szepesi T
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1713-7. PubMed ID: 6090368
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
[TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy of carcinoma in bilharzial bladder using a three-fractions per day regimen.
Zaghloul MS; Awwad HK; Soliman O; Omar S; el Badawy S; Barsoum M; Mocktar N; Amer F
Radiother Oncol; 1986 Aug; 6(4):257-65. PubMed ID: 3534966
[TBL] [Abstract][Full Text] [Related]
11. A national trial on the treatment of invasive bladder cancer.
Arnold EP; Bailey C; Burry AF; Bydder PV; Firth LA; Gowland S; Gray AJ; Mcllroy R
N Z Med J; 1981 Apr; 93(682):273-5. PubMed ID: 7019784
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
Hoskin PJ; Saunders MI; Dische S
Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer. The selection of patients for treatment by full-dose irradiation.
Shipley WU; Rose MA
Cancer; 1985 May; 55(9 Suppl):2278-84. PubMed ID: 3919933
[TBL] [Abstract][Full Text] [Related]
15. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
Schwade JG; Kinsella TJ; Kelly B; Rowland J; Johnston M; Glatstein E
Cancer Invest; 1984; 2(2):91-5. PubMed ID: 6733563
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
Kleine W; Stange S; Nagy D; Ladner HA
Strahlentherapie; 1982 Aug; 158(8):498-503. PubMed ID: 6814020
[TBL] [Abstract][Full Text] [Related]
18. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.
Fazekas J; Pajak TF; Wasserman T; Marcial V; Davis L; Kramer S; Rotman M; Stetz J
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1155-60. PubMed ID: 3301758
[TBL] [Abstract][Full Text] [Related]
19. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
[TBL] [Abstract][Full Text] [Related]
20. Misonidazole combined with radiotherapy in the treatment of non-small cell lung cancer. A randomized double-blind trial.
Jakobsson M; Taskinen PJ; Kylmämaa T
Strahlenther Onkol; 1987 Feb; 163(2):90-3. PubMed ID: 3031840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]